Skip to main content
PMC home page
Journal of Clinical Pathology. Supplement (Royal College of Pathologists) logoLink to Journal of Clinical Pathology. Supplement (Royal College of Pathologists)
. 1979;13:97–106. doi: 10.1136/jcp.s3-13.1.97

Tissue-specific antibodies in myasthenia gravis.

A Vincent
PMCID: PMC1521595  PMID: 391832

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aharonov A., Abramsky O., Tarrab-Hazdai R., Fuchs S. Humoral antibodies to acetylcholine receptor in patients with myasthenia gravis. Lancet. 1975 Aug 23;2(7930):340–342. doi: 10.1016/s0140-6736(75)92779-8. [DOI] [PubMed] [Google Scholar]
  2. Albuquerque E. X., Lebeda F. J., Appel S. H., Almon R., Kauffman F. C., Mayer R. F., Narahashi T., Yeh J. Z. Effects of normal and myasthenic serum factors on innervated and chronically denervated mammalian muscles. Ann N Y Acad Sci. 1976;274:475–492. doi: 10.1111/j.1749-6632.1976.tb47709.x. [DOI] [PubMed] [Google Scholar]
  3. Almon R. R., Andrew C. G., Appel S. H. Serum globulin in myasthenia gravis: inhibition of alpha-bungarotoxin binding to acetylcholine receptors. Science. 1974 Oct 4;186(4158):55–57. doi: 10.1126/science.186.4158.55. [DOI] [PubMed] [Google Scholar]
  4. Almon R. R., Appel S. H. Interaction of myasthenic serum globulin with the acetylcholine receptor. Biochim Biophys Acta. 1975 May 30;393(1):66–77. doi: 10.1016/0005-2795(75)90217-2. [DOI] [PubMed] [Google Scholar]
  5. Appel S. H., Anwyl R., McAdams M. W., Elias S. Accelerated degradation of acetylcholine receptor from cultured rat myotubes with myasthenia gravis sera and globulins. Proc Natl Acad Sci U S A. 1977 May;74(5):2130–2134. doi: 10.1073/pnas.74.5.2130. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bender A. N., Ringel S. P., Engel W. K., Daniels M. P., Vogel Z. Myasthenia gravis: a serum factor blocking acetylcholine receptors of the human neuromuscular junction. Lancet. 1975 Mar 15;1(7907):607–609. doi: 10.1016/s0140-6736(75)91886-3. [DOI] [PubMed] [Google Scholar]
  7. Berg D. K., Hall Z. W. Loss of alpha-bungarotoxin from junctional and extrajunctional acetylcholine receptors in rat diaphragm muscle in vivo and in organ culture. J Physiol. 1975 Nov;252(3):771–789. doi: 10.1113/jphysiol.1975.sp011169. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Bevan S., Kullberg R. W., Heinemann S. F. Human myasthenic sera reduce acetylcholine sensitivity of human muscle cells in tissue culture. Nature. 1977 May 19;267(5608):263–265. doi: 10.1038/267263a0. [DOI] [PubMed] [Google Scholar]
  9. Bucknall R. C. Myasthenia associated with D-penicillamine therapy in rheumatoid arthritis. Proc R Soc Med. 1977;70 (Suppl 3):114–117. [PMC free article] [PubMed] [Google Scholar]
  10. Datta S. K., Schwartz R. S. Editorial: Infectious (?) myasthenia. N Engl J Med. 1974 Dec 12;291(24):1304–1305. doi: 10.1056/NEJM197412122912411. [DOI] [PubMed] [Google Scholar]
  11. Downes J. M., Greenwood B. M., Wray S. H. Auto-immune aspects of myasthenia gravis. Q J Med. 1966 Jan;35(137):85–105. [PubMed] [Google Scholar]
  12. Drachman D. B., Angus C. W., Adams R. N., Kao I. Effect of myasthenic patients' immunoglobulin on acetylcholine receptor turnover: selectivity of degradation process. Proc Natl Acad Sci U S A. 1978 Jul;75(7):3422–3426. doi: 10.1073/pnas.75.7.3422. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Drachman D. B., Angus C. W., Adams R. N., Michelson J. D., Hoffman G. J. Myasthenic antibodies cross-link acetylcholine receptors to accelerate degradation. N Engl J Med. 1978 May 18;298(20):1116–1122. doi: 10.1056/NEJM197805182982004. [DOI] [PubMed] [Google Scholar]
  14. Drachman D. B. Myasthenia gravis (first of two parts). N Engl J Med. 1978 Jan 19;298(3):136–142. doi: 10.1056/NEJM197801192980305. [DOI] [PubMed] [Google Scholar]
  15. ELMQVIST D., HOFMANN W. W., KUGELBERG J., QUASTEL D. M. AN ELECTROPHYSIOLOGICAL INVESTIGATION OF NEUROMUSCULAR TRANSMISSION IN MYASTHENIA GRAVIS. J Physiol. 1964 Nov;174:417–434. doi: 10.1113/jphysiol.1964.sp007495. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Engel A. G., Lambert E. H., Howard F. M. Immune complexes (IgG and C3) at the motor end-plate in myasthenia gravis: ultrastructural and light microscopic localization and electrophysiologic correlations. Mayo Clin Proc. 1977 May;52(5):267–280. [PubMed] [Google Scholar]
  17. Engel E. K., Trotter J. L., McFarlin D. E., McIntosh C. L. Thymic epithelial cell contains acetylcholine receptor. Lancet. 1977 Jun 18;1(8025):1310–1311. doi: 10.1016/s0140-6736(77)91343-5. [DOI] [PubMed] [Google Scholar]
  18. Fambrough D. M., Drachman D. B., Satyamurti S. Neuromuscular junction in myasthenia gravis: decreased acetylcholine receptors. Science. 1973 Oct 19;182(4109):293–295. doi: 10.1126/science.182.4109.293. [DOI] [PubMed] [Google Scholar]
  19. Fenichel G. M. Clinical syndromes of myasthenia in infancy and childhood. A review. Arch Neurol. 1978 Feb;35(2):97–103. doi: 10.1001/archneur.1978.00500260035009. [DOI] [PubMed] [Google Scholar]
  20. Green D. P., Miledi R., Vincent A. Neuromuscular transmission after immunization against acetylcholine receptors. Proc R Soc Lond B Biol Sci. 1975 Apr 29;189(1094):57–68. doi: 10.1098/rspb.1975.0041. [DOI] [PubMed] [Google Scholar]
  21. HESS A., PILAR G. SLOW FIBRES IN THE EXTRAOCULAR MUSCLES OF THE CAT. J Physiol. 1963 Dec;169:780–798. doi: 10.1113/jphysiol.1963.sp007296. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Henry K. An unusual thymic tumour with a striated muscle (myoid) component (with a brief review of the literature on myoid cells). Br J Dis Chest. 1972 Oct;66(4):291–299. doi: 10.1016/0007-0971(72)90050-2. [DOI] [PubMed] [Google Scholar]
  23. Ito Y., Miledi R., Vincent A., Newsom-Davis J. Acetylcholine receptors and end-plate electrophysiology in myasthenia gravis. Brain. 1978 Jun;101(2):345–368. doi: 10.1093/brain/101.2.345. [DOI] [PubMed] [Google Scholar]
  24. Kao I., Drachman D. B. Myasthenic immunoglobulin accelerates acetylcholine receptor degradation. Science. 1977 Apr 29;196(4289):527–529. doi: 10.1126/science.850793. [DOI] [PubMed] [Google Scholar]
  25. Kao I., Drachman D. B. Thymic muscle cells bear acetylcholine receptors: possible relation to myasthenia gravis. Science. 1977 Jan 7;195(4273):74–75. doi: 10.1126/science.831257. [DOI] [PubMed] [Google Scholar]
  26. Lefvert A. K., Bergström K. Acetylcholine receptor antibody in myasthenia gravis: purification and characterization. Scand J Immunol. 1978;8(6):525–533. doi: 10.1111/j.1365-3083.1978.tb00552.x. [DOI] [PubMed] [Google Scholar]
  27. Lefvert A. K., Bergström K., Matell G., Osterman P. O., Pirskanen R. Determination of acetylcholine receptor antibody in myasthenia gravis: clinical usefulness and pathogenetic implications. J Neurol Neurosurg Psychiatry. 1978 May;41(5):394–403. doi: 10.1136/jnnp.41.5.394. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Lindstrom J. M., Engel A. G., Seybold M. E., Lennon V. A., Lambert E. H. Pathological mechanisms in experimental autoimmune myasthenia gravis. II. Passive transfer of experimental autoimmune myasthenia gravis in rats with anti-acetylcholine recepotr antibodies. J Exp Med. 1976 Sep 1;144(3):739–753. doi: 10.1084/jem.144.3.739. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Lindstrom J. M., Seybold M. E., Lennon V. A., Whittingham S., Duane D. D. Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value. Neurology. 1976 Nov;26(11):1054–1059. doi: 10.1212/wnl.26.11.1054. [DOI] [PubMed] [Google Scholar]
  30. Lindstrom J., Campbell M., Nave B. Specificities of antibodies to acetylcholine receptors. Muscle Nerve. 1978 Mar-Apr;1(2):140–145. doi: 10.1002/mus.880010206. [DOI] [PubMed] [Google Scholar]
  31. Lisak R. P., Abdou N. I., Zweiman B., Zmijewski C., Penn A. S. Aspects of lymphocyte function in myasthenia gravis. Ann N Y Acad Sci. 1976;274:402–410. doi: 10.1111/j.1749-6632.1976.tb47701.x. [DOI] [PubMed] [Google Scholar]
  32. McFarlin D. E., Engel W. K., Strauss A. J. Does myasthenic serum bind to the neuromuscular junction? Ann N Y Acad Sci. 1966 Jan 26;135(1):656–663. doi: 10.1111/j.1749-6632.1966.tb45512.x. [DOI] [PubMed] [Google Scholar]
  33. Monnier V. M., Fulpius B. W. A radioimmunoassay for the quantitative evaluation of anti-human acetylcholine receptor antibodies in myasthenia gravis. Clin Exp Immunol. 1977 Jul;29(1):16–22. [PMC free article] [PubMed] [Google Scholar]
  34. Newsom-Davis J., Pinching A. J., Vincent A., Wilson S. G. Function of circulating antibody to acetylcholine receptor in myasthenia gravis: investigation by plasma exchange. Neurology. 1978 Mar;28(3):266–272. doi: 10.1212/wnl.28.3.266. [DOI] [PubMed] [Google Scholar]
  35. Newsom-Davis J., Wilson S. G., Vincent A., Ward C. D. Long-term effects of repeated plasma exchange in myasthenia gravis. Lancet. 1979 Mar 3;1(8114):464–468. doi: 10.1016/s0140-6736(79)90823-7. [DOI] [PubMed] [Google Scholar]
  36. Nicholson G. A., Appel S. H. Is there acetylcholine receptor in human thymus? J Neurol Sci. 1977 Oct;34(1):101–108. doi: 10.1016/0022-510x(77)90095-8. [DOI] [PubMed] [Google Scholar]
  37. Oosterhuis H. J., Feltkamp T. E., van Rossum A. L., van den Berg-Loonen P. M., Nijenhuis L. E. HL-A antigens, autoantibody production, and associated diseases in thymoma patients, with and without myasthenia gravis. Ann N Y Acad Sci. 1976;274:468–474. doi: 10.1111/j.1749-6632.1976.tb47708.x. [DOI] [PubMed] [Google Scholar]
  38. Patrick J., Lindstrom J. Autoimmune response to acetylcholine receptor. Science. 1973 May 25;180(4088):871–872. doi: 10.1126/science.180.4088.871. [DOI] [PubMed] [Google Scholar]
  39. Pinching A. J., Peters D. K. Remission of myasthenia gravis following plasma-exchange. Lancet. 1976 Dec 25;2(8000):1373–1376. doi: 10.1016/s0140-6736(76)91917-6. [DOI] [PubMed] [Google Scholar]
  40. Russell A. S., Lindstrom J. M. Penicillamine-induced myasthenia gravis associated with antibodies to acetylcholine receptor. Neurology. 1978 Aug;28(8):847–849. doi: 10.1212/wnl.28.8.847. [DOI] [PubMed] [Google Scholar]
  41. Santa T., Engel A. G., Lambert E. H. Histometric study of neuromuscular junction ultrastructure. I. Myasthenia gravis. Neurology. 1972 Jan;22(1):71–82. doi: 10.1212/wnl.22.1.71. [DOI] [PubMed] [Google Scholar]
  42. Scratcherd T. Two of the newer 'gastrointestinal hormones'. Clin Sci (Lond) 1979 Jan;56(1):1–7. doi: 10.1042/cs0560001. [DOI] [PubMed] [Google Scholar]
  43. Shibuya N., Mori K., Nakazawa Y. Serum factor blocks neuromuscular transmission in myasthenia gravis: electrophysiologic study with intracellular microelectrodes. Neurology. 1978 Aug;28(8):804–811. doi: 10.1212/wnl.28.8.804. [DOI] [PubMed] [Google Scholar]
  44. Smith C. I., Hammarström L., Berg J. V. Role of virus for the induction of myasthenia gravis. Eur Neurol. 1978;17(4):181–187. doi: 10.1159/000114943. [DOI] [PubMed] [Google Scholar]
  45. Stanley E. F., Drachman D. B. Effect of myasthenic immunoglobulin on acetylcholine receptors of intact mammalian neuromuscular junctions. Science. 1978 Jun 16;200(4347):1285–1287. doi: 10.1126/science.663610. [DOI] [PubMed] [Google Scholar]
  46. Strauss A. J., Kemp P. G., Douglas S. D. Myasthenia gravis. Lancet. 1966 Apr 2;1(7440):772–773. doi: 10.1016/s0140-6736(66)90931-7. [DOI] [PubMed] [Google Scholar]
  47. Tindall R. S., Cloud R., Luby J., Rosenberg R. N. Serum antibodies to cytomegalovirus in myasthenia gravis: effects of thymectomy and steroids. Neurology. 1978 Mar;28(3):273–277. doi: 10.1212/wnl.28.3.273. [DOI] [PubMed] [Google Scholar]
  48. Toyka K. V., Drachman D. B., Griffin D. E., Pestronk A., Winkelstein J. A., Fishbeck K. H., Kao I. Myasthenia gravis. Study of humoral immune mechanisms by passive transfer to mice. N Engl J Med. 1977 Jan 20;296(3):125–131. doi: 10.1056/NEJM197701202960301. [DOI] [PubMed] [Google Scholar]
  49. VAN DER GELD H., FELTKAMP T. E., VAN LOGHEM J., OOSTERHUIS H. J., BIEMOND A. MULTIPLE ANTIBODY PRODUCTION IN MYASTHENIA GRAVIS. Lancet. 1963 Aug 24;2(7304):373–375. doi: 10.1016/s0140-6736(63)93055-1. [DOI] [PubMed] [Google Scholar]
  50. Vincent A., Newsom-Davis J. Absence of anti-acetylcholine receptor antibodies in congenital myasthenia gravis. Lancet. 1979 Feb 24;1(8113):441–442. doi: 10.1016/s0140-6736(79)90918-8. [DOI] [PubMed] [Google Scholar]
  51. Vincent A., Newsom-Davis J., Martin V. Anti-acetylcholine receptor antibodies in D-penicillamine-associated myasthenia gravis. Lancet. 1978 Jun 10;1(8076):1254–1254. doi: 10.1016/s0140-6736(78)92481-9. [DOI] [PubMed] [Google Scholar]
  52. Vincent A., Newsom-Davis J. alpha-Bungarotoxin and anti-acetylcholine receptor antibody binding to the human acetylcholine receptor. Adv Cytopharmacol. 1979;3:269–278. [PubMed] [Google Scholar]
  53. Vincent A., Scadding G. K., Thomas H. C., Newsom-Davis J. In-vitro synthesis of anti-acetylcholine-receptor antibody by thymic lymphocytes in myasthenia gravis. Lancet. 1978 Feb 11;1(8059):305–307. doi: 10.1016/s0140-6736(78)90073-9. [DOI] [PubMed] [Google Scholar]
  54. Wekerle H., Ketelsen U. P. Intrathymic pathogenesis and dual genetic control of myasthenia gravis. Lancet. 1977 Mar 26;1(8013):678–680. doi: 10.1016/s0140-6736(77)92118-3. [DOI] [PubMed] [Google Scholar]
  55. Wekerle T. H., paterson B., Ketelsen U., Feldman M. Striated muscle fibres differentiate in monolayer cultures of adult thymus reticulum. Nature. 1975 Aug 7;256(5517):493–494. doi: 10.1038/256493a0. [DOI] [PubMed] [Google Scholar]
  56. van der Geld H. W., Strauss A. J. Myasthenia gravis. Immunological relationship between striated muscle and thymus. Lancet. 1966 Jan 8;1(7428):57–60. doi: 10.1016/s0140-6736(66)92356-7. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology. Supplement (Royal College of Pathologists). are provided here courtesy of BMJ Publishing Group

RESOURCES